The importance of HLA type as a risk factor for the development of diabetic retinopathy remains unclear because of the relatively small numbers of patients studied in each of the recent communications [1, 2, 3, 4] . We have HLA typed a larger series of patients with and without proliferative retinopathy than has hitherto been reported and present this data and the combined results of published reports. The alleles of properdin factor B (Bf) have also been determined in our patients. Previous reports have not considered Bf alleles in relation to retinopathy.
Dear Sir,
The importance of HLA type as a risk factor for the development of diabetic retinopathy remains unclear because of the relatively small numbers of patients studied in each of the recent communications [1, 2, 3, 4] . We have HLA typed a larger series of patients with and without proliferative retinopathy than has hitherto been reported and present this data and the combined results of published reports. The alleles of properdin factor B (Bf) have also been determined in our patients. Previous reports have not considered Bf alleles in relation to retinopathy.
The patients were routinely attending the diabetic clinics at Dudley Road or the General Hospitals, Birmingham. All patients were European caucasians who had juvenile onset (< age 30 years), insulin dependent diabetes for at least 10 years. Two groups of patients were selected: group A -26 patients who had no retinopathy or only minimal background retinopathy (Hammersmith grade A haemorrhages and exudates) intact vibration sense and ankle reflexes, less than 2 + proteinuria, non-isehaemic feet and no other major complications of diabetes. Group B -22 patients who had active or treated proliferative retinopathy with or without other diabetic complications. All other patients were excluded. Groups A and B had similar mean ages (40 + 13 years and 45 + 7 years respectively) and durations of diabetes (23 _+ 8 years and 25 + 7 years respectively). The number of patients who were HLA B8, B15 and B18 were compared with a control group of 380 West Midland European caucasions (Table 1 ).
In agreement with previous studies [5, 6] there was a significant increase in the overall frequency of HLA B8 (p = < 0.01) and B 15 (p = < 0.05) and a decreased frequency of B7 (p = < 0.001) compared with controls. In the present series there were no significant differences between the frequency of any HLA type in groups A and B. As with other reports, true differences may not be apparent because of the relatively small number of patients studied. The results have therefore been combined with the data from four other reports of HLA typing of patients selected on similar criteria (Table 1) . Combining data from several centres in Western Europe has the disadvantage of obscuring local variations but would be expected to show up a strong widespread association between an HLA type and proliferative retinopathy if one existed. Overall the diabetics had an increased frequency of B8 (p = < 0.001) B15 (p = < 0.001) and B18 (p = < 0.001) and a decreased frequency of B7 (p = < 0.001) compared with the combined control population. Three out of four series reported a higher frequency of B8 in patients with severe retinopathy than in those who had minor complications. However, in the combined data no significant differences were detected between the 89 patients who had no retinipathy or minimal background retinopathy and the 128 who had proliferative changes. These results do not confirm the reports of an increased frequency of HLA B8 [1] and B15 [12] in patients with proliferative retinopathy.
In the present series the alleles of properdin factor B occurred with similar gene frequencies in the diabetics and the The numbers (n) of patients and controls studied and the number of subjects with HLA types B7, B8, B15 and B18 reported by each author a All patients were insulin dependent diabetics with visual impairment and severe renal failure ences were detected between groups A and B. Three previous reports describe an association between BfF1 and insulin dependent diabetes [7, 8, 9] but two others found no association [10, 11] . The discrepancies may be due to geographical variations or to differences in the selection of patients studied [9] .
The available data provide no evidence that HLA type or Bf allele are genetic markers for proliferative retinopathy. 
Rapid Fluctuations in Glycosylated Haemoglobin Concentration as Related to Acute Changes in Blood Glucose
Sir, In a recent article [1] Dr. Bolli and co-workers reported that HbAI levels decreased significantly after only 3 days of treatment with the "artificial endocrine pancreas" (Biostator). This and other in vivo and in vitro observations [2] [3] [4] [5] raise questions concerning the concept, based on previous clinical studies [6--8] , that HbAic degradation takes place slowly (on the order of weeks or months) and that HbAic levels therefore are clinically useful to assess long-term blood glucose control.
It is of note that the original methods of HbAIc determination, on which this concept was based, included prolonged dialysis of the haemolysates, whereas many of the more recent modifications of this technique, including high pressure liquid chromatography, use nondialysed samples, and the microcolumn commercial methods, which include a haemolysing agent, use whole blood [9] [10] [11] . Although it is unclear whether all the clinical studies indicating rapid fluctuations in glycohacmoglobins utilized nondialysed samples for HbAic analysis, it would appear that most did. It is well known that an unstable, dialysable, Schiffbase form of HbAic may be formed as an intermediate for the stable ketoamine end-product [12] . It is therefore likely that the dialysis step is important to minimise the effect of acute changes in blood glucose on the level of glycohaemoglobin.
In order to evaluate this possibility, one of us (J. D.) determined blood glucose and HbAIc concentrations in a group of 24 ambulatory diabetic children, fasting and 6 hours postprandially, using three methods for HbAI determinations: the macrocolumn method of Schnek and Schroeder, as modified by Schwartz et al.
